Neurological Disorder Diagnostics
Neurological Disorder Diagnostics Market By Disorder Type (Genetic Neurological Disorders, Immunological Neurological Disorders, Paraneoplastic Syndrome, Paraproteinemic Neuropathies), By Technology Type (Imaging, In Vitro Diagnostics), Industry Analysis, Trends, and Forecast 2019 – 2025Report ID: BMRC 249 | Number of pages: 200 | Publish Date: May 2019 | Category: Lifesciences and Healthcare
Neurological Disorder Diagnostics Market is valued around USD 11305.69 Million in 2018 and expected to reach USD 18273.57 Million by 2025 with the CAGR of 7.1% over the forecast period. Increased prevalence of neurological disorders and increase in technological advancements are the key drivers for Global Neurological Disorder Diagnostics Market. Neurological disorder diagnostics market report published by the Brandessence Market Research and Consulting Pvt. Ltd. provides the detail information about neurological disorder diagnostics market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of market. This report consists of regional segmentation with disorder type, technology type, end user. Neurological disorder diagnostics are the various medical devices used for the diagnosis of various neurological disorders such as Parkinson’s disease, Alzheimer’s disease and others. These medical devices include various imaging devices such as CT Scan, Magnetic resonance Imaging, biopsy and others. Increasing prevalence of these disorders has led to the increased demand for better diagnostics and better treatment over the period of time. There are various factors driving the growth of the neurological disorder diagnostics market, one of the major factors expected to drive the growth of this market is increase in the prevalence of neurological disorders and others coupled with increased awareness among people over the period of time. As per Alzheimer’s Association 2018 report, there were around 5.7million of Americans living with Alzheimer’s dementia in 2018 which includes an estimated 5.5 million people age 65 and older and approximately 200,000 individuals under age 65 who have younger-onset Alzheimer’s. Furthermore, various collaborations among major market players are also expected to promote the growth of neurological disorder diagnostics over the forecast period. Moreover, increase in various technological advancements for the development of novel diagnostics are anticipated to fuel drive the growth of market. However, high costs of these medical devices are expected to hinder the growth of neurological disorder diagnostics market. Global neurological disorder diagnostics market report covers prominent players like Koninklijke Philips N.V., Masimo Corporation, York Instruments Ltd., Esaote SpA, Neusoft Medical Systems, NeuroLogica Corporation, General Electric Company, Canon Medical Systems Corporation and others. Neurological Disorder Diagnostics Market Segmentation – By Disorder Type Genetic Neurological Disorders Immunological Neurological Disorders Paraneoplastic Syndrome Paraproteinemic Neuropathies Others By Technology Type Imaging In Vitro Diagnostics By End-User Hospitals Ambulatory Surgical Centers Diagnostics Centers Others By Region North America U.S. Canada Europe UK France Germany Italy Asia Pacific China Japan India Southeast Asia Latin America Brazil Mexico Middle East and Africa GCC
Interested in this report?
Get your sample now!